Senseonics Holdings Inc (SENS)
0.3316
-0.01
(-1.63%)
USD |
NYAM |
Nov 05, 16:00
0.3355
0.00 (0.00%)
After-Hours: 20:00
Senseonics Holdings Enterprise Value: 148.76M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 148.76M |
| November 01, 2024 | 150.15M |
| October 31, 2024 | 149.40M |
| October 30, 2024 | 151.49M |
| October 29, 2024 | 155.40M |
| October 28, 2024 | 152.88M |
| October 25, 2024 | 149.24M |
| October 24, 2024 | 154.81M |
| October 23, 2024 | 151.76M |
| October 22, 2024 | 162.63M |
| October 21, 2024 | 155.83M |
| October 18, 2024 | 160.22M |
| October 17, 2024 | 155.67M |
| October 16, 2024 | 158.45M |
| October 15, 2024 | 156.74M |
| October 14, 2024 | 162.09M |
| October 11, 2024 | 157.81M |
| October 10, 2024 | 144.90M |
| October 09, 2024 | 149.83M |
| October 08, 2024 | 147.90M |
| October 07, 2024 | 151.28M |
| October 04, 2024 | 151.92M |
| October 03, 2024 | 146.56M |
| October 02, 2024 | 147.80M |
| October 01, 2024 | 148.76M |
| Date | Value |
|---|---|
| September 30, 2024 | 155.51M |
| September 27, 2024 | 155.29M |
| September 26, 2024 | 153.74M |
| September 25, 2024 | 161.02M |
| September 24, 2024 | 153.53M |
| September 23, 2024 | 154.54M |
| September 20, 2024 | 161.08M |
| September 19, 2024 | 165.04M |
| September 18, 2024 | 187.86M |
| September 17, 2024 | 201.41M |
| September 16, 2024 | 179.55M |
| September 13, 2024 | 186.14M |
| September 12, 2024 | 186.14M |
| September 11, 2024 | 179.18M |
| September 10, 2024 | 150.37M |
| September 09, 2024 | 149.19M |
| September 06, 2024 | 140.94M |
| September 05, 2024 | 158.88M |
| September 04, 2024 | 166.92M |
| September 03, 2024 | 168.63M |
| August 30, 2024 | 176.61M |
| August 29, 2024 | 173.98M |
| August 28, 2024 | 167.88M |
| August 27, 2024 | 184.59M |
| August 26, 2024 | 182.45M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
120.82M
Minimum
Oct 28 2020
2.004B
Maximum
Feb 16 2021
499.09M
Average
270.30M
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 211.48B |
| DexCom Inc | 27.17B |
| Baxter International Inc | 29.14B |
| Boston Scientific Corp | 133.49B |
| Perspective Therapeutics Inc | 530.78M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -20.29M |
| Revenue (Quarterly) | 4.865M |
| Total Expenses (Quarterly) | 24.36M |
| EPS Diluted (Quarterly) | -0.03 |
| Gross Profit Margin (Quarterly) | 6.13% |
| Profit Margin (Quarterly) | -417.0% |
| Earnings Yield | -39.20% |
| Normalized Earnings Yield | -37.17 |